parthenolide has been researched along with Nerve Degeneration in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JS; Jung, J; Kim, JM; Kim, SH; Yeo, SG | 1 |
| Che, Y; Feng, X; Liu, Q; Tang, X; Zhang, S; Zhu, D | 1 |
| Blum, D; Nissou, MF; Torch, S; Verna, JM | 1 |
3 other study(ies) available for parthenolide and Nerve Degeneration
| Article | Year |
|---|---|
Inhibitory effect of parthenolide on peripheral nerve degeneration.
Topics: Axons; Humans; Nerve Degeneration; Nerve Regeneration; Peripheral Nervous System Diseases; Schwann Cells; Sciatic Nerve; Sesquiterpenes | 2023 |
The parthenolide derivative ACT001 synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson's disease in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiparkinson Agents; Apoptosis; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Inflammation; Levodopa; Male; Mice; Mice, Inbred BALB C; Nerve Degeneration; Parkinson Disease; Parkinsonian Disorders; Sesquiterpenes | 2020 |
6-hydroxydopamine-induced nuclear factor-kappa B activation in PC12 cells.
Topics: Animals; Apoptosis; Drug Interactions; Minor Histocompatibility Antigens; Nerve Degeneration; NF-kappa B; Oxidative Stress; Oxidopamine; PC12 Cells; Plant Extracts; Protective Agents; Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Sesquiterpenes | 2001 |